High throughput formulation design for a stable lyophilized virus-like particle vaccine against Group A Streptococcu by Chuan, Yap
Engineering Conferences International
ECI Digital Archives
Vaccine Technology IV Proceedings
Spring 5-22-2012
High throughput formulation design for a stable
lyophilized virus-like particle vaccine against Group
A Streptococcu
Yap Chuan
The University of Queensland
Follow this and additional works at: http://dc.engconfintl.org/vaccine_iv
Part of the Biomedical Engineering and Bioengineering Commons
This Conference Proceeding is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion in
Vaccine Technology IV by an authorized administrator of ECI Digital Archives. For more information, please contact franco@bepress.com.
Recommended Citation
Yap Chuan, "High throughput formulation design for a stable lyophilized virus-like particle vaccine against Group A Streptococcu" in
"Vaccine Technology IV", B. Buckland, University College London, UK; J. Aunins, Janis Biologics, LLC; P. Alves , ITQB/IBET; K.
Jansen, Wyeth Vaccine Research Eds, ECI Symposium Series, (2013). http://dc.engconfintl.org/vaccine_iv/18
High-throughput, low
formulation screening for Group A 
Streptococcus VLP vaccine 
Yap 




 Virus-like particle (VLP) aggregation in 
production and storage
 Formulation screening bottleneck







































































Dynamic light scattering (DLS): cuvette 
operation 
 Manual handling
 Wait for temperature 
stability 
9
 Sample size not 
trivial: 150-200 µL
DLS: well plate format
Wyatt DynaPro Plate Reader I 96
10














































Murine polyomavirus VLPs in PBS
 5 uL sample
 0.4 ug/mL VLP
 2 uL silicone oil
 Plate centrifuged
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 Asymmetrical flow field-
with multiangle light-scattering (MALS)
 Transmission electron microscopy (TEM)  
flow fractionation (AF4) 
17
AF4 with multi-angle light scattering (MALS) 






Murine polyomavirus VLPs in PBS




VLPs in supernatant 
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AF4
VLPs heated to 48°C
100 nm
TEM







Well plate format DLS










Heat rate: 0.4°C/min, hold at set temperature for 1 h 
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Starts aggregating










































































































































































































































































































































































































 25 conditions: 50 ug sample 
 Increased freeze thawed and freeze
stabilities recovery to over 90%
 Increased VLP retention after one
storage
 Stabilising formulation optimised





























National Health and Medical Research Council
Queensland Smart Futures Fund








Shi et al., J. Pharm. Sci., 94, 1538
Stable
1250 mM
mM NaCl, 26°C 
-1551
NaCl, 4°C 
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